Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Dec;26(1):1073274819874122.
doi: 10.1177/1073274819874122.

Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening

Affiliations

Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening

Laura Steponaviciene et al. Cancer Control. 2019 Jan-Dec.

Abstract

Objective: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP).

Methods: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed.

Results: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant.

Conclusions: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries.

Keywords: breast cancer; interval cancers; program sensitivity; screening program.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

Cited by

References

    1. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L, eds. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg, Europe: Office for Official Publications of the European Communities; 2006. - PubMed
    1. NHS Breast Screening Radiologists Quality Assurance Committee. Quality Assurance Guidelines for Breast Cancer Screening Radiology. Sheffield, England: NHSBSP Publications; 2005.
    1. Bordas P, Jonsson H, Nystrom L, Lenner P. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden. J Med Screen. 2009;16(1):39–45. - PubMed
    1. Renart-Vicens G, Puig-Vives M, Albanell J, et al. Evaluation of the interval cancer rate and its determinants on the Girona health region’s early breast cancer detection program. BMC Cancer. 2014;14:558. - PMC - PubMed
    1. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L, eds. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed Supplements Luxembourg, Europe: European Commission, Publications Office of the European Union; 2013. - PubMed